Literature DB >> 19273637

Phenotypic and genotypic assays for detecting the prevalence of metallo-beta-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital.

R Uma Karthika1, R Srinivasa Rao1, Suchismita Sahoo1, P Shashikala2, Reba Kanungo2, S Jayachandran1, K Prashanth1.   

Abstract

Nosocomial infections caused by Acinetobacter baumannii often prove difficult to treat owing to their multiple drug resistance. Carbapenems play a pivotal role in the management of severe Acinetobacter infections. However, reports of carbapenem resistance have been increasing alarmingly due to production of a variety of carbapenemases including metallo-beta-lactamases (MBLs). This study investigated by both phenotypic and genotypic assays the prevalence of MBLs in a total of 55 A. baumannii strains isolated from a South Indian tertiary care hospital. Random amplified polymorphic DNA (RAPD) genotyping and antimicrobial susceptibility testing for nine clinically relevant antibiotics was done for characterization of isolates. Phenotypic expression of MBLs was examined by a simple double disc synergy (DDS) test, and the presence of the most frequent MBL coding genes, bla(IMP1) and bla(VIM2), was checked by PCR. RAPD analysis generated six clusters of isolates and there was very little correlation between RAPD clusters and resistant profiles. Most of the isolates showed complete or high resistance to imipenem (100 %), meropenem (89 %), amikacin (80 %), cefotaxime (89 %) and ciprofloxacin (72 %). In addition, 44 % of isolates showed a high MIC level (> or =16 microg ml(-1)) for meropenem. Thirty-nine isolates (70.9 %) were positive for MBL production by the DDS test while bla(IMP1) gene amplification was seen only in 23 isolates (42 %). Interestingly, none of the isolates showed amplification of bla(VIM2). Further investigations on DDS-positive/PCR-negative isolates by spectrophotometric assay showed MBL activity in most of the isolates, suggesting involvement of other genes. The high incidence of isolates possessing MBL activity in the present study represents an emerging threat of complete resistance to carbapenems among Acinetobacter spp. in India.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273637     DOI: 10.1099/jmm.0.002105-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.

Authors:  S Roy; R Viswanathan; A Singh; P Das; S Basu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-21       Impact factor: 3.267

2.  Comparative Evaluation of Four Phenotypic Tests for Detection of Metallo-β-Lactamase and Carbapenemase Production in Acinetobacter baumannii.

Authors:  Aparna Shivaprasad; Beena Antony; Poornima Shenoy
Journal:  J Clin Diagn Res       Date:  2014-05-15

3.  Emergence of tigecycline & colistin resistant Acinetobacter baumanii in patients with complicated urinary tract infections in north India.

Authors:  Neelam Taneja; Gagandeep Singh; Meenakshi Singh; Meera Sharma
Journal:  Indian J Med Res       Date:  2011-06       Impact factor: 2.375

4.  Multiple drug resistant carbapenemases producing Acinetobacter baumannii isolates harbours multiple R-plasmids.

Authors:  Rajagopalan Saranathan; Pagal Sudhakar; R Uma Karthika; Santosh Kumar Singh; P Shashikala; Reba Kanungo; K Prashanth
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

5.  Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.

Authors:  David P Kateete; Ritah Nakanjako; Moses Okee; Moses L Joloba; Christine F Najjuka
Journal:  BMC Res Notes       Date:  2017-07-14

6.  Prevalence and risk factors of Metallo β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in burns and surgical wards in a tertiary care hospital.

Authors:  Simit H Kumar; Anuradha S De; Sujata M Baveja; Madhuri A Gore
Journal:  J Lab Physicians       Date:  2012-01

7.  Usefulness of phenotypic and genotypic methods for metallo-beta-lactamases detection in carbapenem-resistant Acinetobacter baumannii strains.

Authors:  Aleksandra Szejbach; Agnieszka Mikucka; Tomasz Bogiel; Eugenia Gospodarek
Journal:  Med Sci Monit Basic Res       Date:  2013-01-21

8.  Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India.

Authors:  Dabet Rynga; Malini Shariff; Monorama Deb
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-09-04       Impact factor: 3.944

9.  Draft Genome Sequence of a Multidrug-Resistant Acinetobacter baumannii PKAB07 Clinical Strain from India Belonging to Sequence Type 195.

Authors:  Rajagopalan Saranathan; Archana Tomar; Pagal Sudhakar; K P Arunkumar; K Prashanth
Journal:  Genome Announc       Date:  2014-03-20

10.  Carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii at Mulago Hospital in Kampala, Uganda (2007-2009).

Authors:  David P Kateete; Ritah Nakanjako; Juliet Namugenyi; Joseph Erume; Moses L Joloba; Christine F Najjuka
Journal:  Springerplus       Date:  2016-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.